Covaxin maker Bharat Biotech has claimed that the vaccine is 77.8 effective overall against Covid-19 after analysing results for its phase 3 trials. Bharat Biotech also claimed that Covaxin provides 65.2 protection against the Delta strain, which was a main driving factor behind India's second wave and is currently the most dominant coronavirus variant in India.